Lhasa Limited shared knowledge shared progress

Events

When

24 June 2021

Where

Online

2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab

WorkshopFree

2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab

We were delighted to welcome external speaker, Dr. Andrew Teasdale to present at this event - Andy is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AstraZeneca expert for a number of key impurity areas, including mutagenic impurities (MIs).

Andy’s presentation covered the following topics:

  • The challenges of controlling potentially mutagenic impurities
  • How using the paper-based approach can reduce the time and effort associated with these challenges
  • AstraZeneca’s experience of how Mirabilis can help further
  • Top tips for applying control option 4.

A recording of Andy's presentation is available from this page.

Following Andy's presentation, Raeesah Saddiq, Business Development Executive within Applied Sciences function at Lhasa Limited, provided an overview of Mirabilis. To arrange a Mirabilis demonstration for your organisation, please get in touch.

 

 

  • Headline Event (shown first above featured)

  • Featured Event

Back to events

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.